This flat-rate pricing model removes the financial anxiety often associated with GLP-1 therapy, especially for patients managing multiple conditions like Graves' disease who may already face high healthcare costs
All articles published on/or before 31 December 2024 were considered, regardless of type, including full-length articles, short reports, case reports, and letters to the editor
Supply shortages have been a problem since 2022 due to high demand and the Therapeutic Goods Administration has asked doctors to prioritise diabetes patients over weight loss patients
This information is crucial for ensuring that your care is safe and effective
Most of the poisons used by humans come from bitter plantsfor example, strychnine and hemlock
If you have a BMI of 38 and HFpEF, you qualify under both Tier 1 (BMI alone) and Tier 2 (BMI 30+ with HFpEF)